Coronary artery bypass surgery: The starting point of a long medical journey

Lee CW Ahn JM Cavalcante R et al. Coronary artery bypass surgery versus drug-eluting stent implantation for left main or multivessel coronary artery disease: A meta-analysis of individual patient data. JACC Cardiovasc Interv 2016; 9: 2481–2489.

Neumann FJ Sousa-Uva M Ahlsson A et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. Epub ahead of print 25 August 2018. DOI: 10.1093/eurheartj/ehy394.

Zafrir B Saliba W Jaffe R et al. Attainment of lipid goals and long-term mortality after coronary-artery bypass surgery. Eur J Prev Cardiol. 2019; 26: 401–408.

Pinho-Gomes AC Azevedo L Ahn JM et al. Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials. J Am Coll Cardiol 2018; 71: 591–602.

Munkhaugen J Sverre E Otterstad JE et al. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients. Eur J Prev Cardiol 2017; 24: 981–989.

Munkhaugen J Otterstad JE Dammen T et al. Prevalence and predictors of elevated C-reactive protein after a coronary heart disease event. Eur J Prev Cardiol 2018; 25: 923–931.

Puymirat E Simon T Cayla G et al. Acute myocardial infarction: Changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French registry of acute ST-elevation or non-ST-elevation myocardial infarction) 1995 to 2015. Circulation 2017; 136: 1908–1919.

Pereira P Kapoor A Sinha A et al. Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery and coronary angioplasty? Indian J Med Res 2017; 146: 722–729.

Looi KL Chow KL Looi JL et al. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery. N Z Med J 2011; 124: 18–27.

Kotseva K Wood D De Backer G et al. Cardiovascular prevention guidelines in daily practice: A comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373: 929–940.

Kurlansky P Herbert M Prince S et al. Coronary artery bypass graft versus percutaneous coronary intervention: Meds matter: Impact of adherence to medical therapy on comparative outcomes. Circulation 2016; 134: 1238–1246.

Barry AR Koshman SL Norris CM et al. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery. Pharmacotherapy 2014; 34: 464–472.

Bandeali SJ Gosch K Alam M et al. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE Registry). Am J Cardiol 2015; 115: 1013–1018.

Peersen K Munkhaugen J Gullestad L et al. The role of cardiac rehabilitation in secondary prevention after coronary events. Eur J Prev Cardiol 2017; 24: 1360–1368.